Jump to section
ZiO Health brings advanced hospital lab testing to the point-of-use allowing greater accessibility to molecular level testing, providing a new route to optimising health and sickness prevention.
Drug dosing models tend to generalise patients' health according to statistics, which can impact drug efficacy. ZiO Health solves this problem with its biosensor technology.
ZiO Health was founded by an experienced team of medical experts, which has shaped its technology considerably. The company uses a combination of machine learning and biosensor technology to improve patient outcomes on an individual level. ZiO numbers the likes of Berkeley and EIT Health as investors, which is testament to the value of its solutions.
ZiO Health is tackling some of the biggest care challenges facing modern healthcare, which is no mean feat. It will need further funding in order to scale its technology and customer base.
Freddie
Company Specialist at Welcome to the Jungle
Neel Patel
(CEO)